/b/veterinary-news/posts/zoetis-launches-breakthrough-treatment-for-canine-atopic-dermatitis Zoetis has launched Cytopoint (lokivetmab), a novel once-monthly injectable treatment for the clinical signs of atopic dermatitis in dogs and the first monoclonal antibody (mAb) therapy approved in the European Union for veterinary use. Zoetis saysen-USTelligent Community 10